Zepbound outduels Wegovy in weight-loss clinical trial
May 14th 2025 at 4:35 pm
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.